The Landmark Series: Multimodality Treatment of Extremity Sarcoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32720044.
- Also identified by DOI 10.1245/s10434-020-08872-1 and PMC identifier PMC6154892.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Multimodality treatment of primary soft tissue sarcoma has evolved over the last 50 years, including seminal studies in amputation versus limb-sparing surgery, incorporation of radiation therapy (XRT), and the continuing controversy over the utilization and efficacy of systemic chemotherapy. We review the landmark studies in the multimodality management of primary extremity and trunk soft tissue sarcoma.